Dr. Steve Goodison: Publication List (July, 2005)


Peer Reviewed Articles (in ascending chronological order)
  1. Goodison S, Kenna S, Ashcroft SJH.
    Control of insulin gene expression by glucose.
    Biochem J 285: 563-568 (1992)
  2. Goodison S, Ashcroft SJH.
    Comparison of rat-I and human insulin gene 5' sequence-mediated transcriptional responses.
    Diabetic Medicine 9: 512-514, (1992)
  3. Goodison S, Ashcroft SJH.
    Human insulin promoter-driven reporter gene expression.
    Biochem Soc Trans 21: 225-226 (1992)
  4. Goodison S, Ashcroft SJH.
    Trans-acting factors and glucose-responsive transcriptional regulation in the insulin gene. In: Physiology and Pathophysiology of the Islets of Langerhans (ed: B Soria). Plenum Press 231-237 (1994)
  5. German M, Ashcroft SJH, Docherty K, Goodison S, Rutter W., Steiner D, et al.
    The Insulin gene promoter
    Diabetes: Vol 4, 1002-1005. (1995)
  6. Goodison S, Miyazaki J, Ashcroft SJH.
    Response to glucose of transcription binding in the rat insulin-I gene promoter.
    Biochem Biophys Res Comm 203: 702-710, (1994)
  7. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E, Tarin D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
    Cancer Research 55, 4273-77 (1995)
  8. Yoshida K, Goodison S, Sugino T, Bolodeoku J, Churchman M, Warren B, Tarin D. Semi-quantitative detection of abnormal CD44 transcripts in colon carcinomas by RT-PCR-enzyme linked immunosorbant assay
    Molecular Diagnosis Vol 1, No 3 167-173 (1996)
  9. Sugino T, Yoshida K, Bolodeoku J, Tahara H, Buley I, Manek S, Wells C, Goodison S, Ide T, Suzuki T, Tahara E, Tarin D. Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens including fine needle aspirates.
    International Journal of Cancer 69, 301-306 (1996)
  10. Goodison S, Yoshida K, Tarin D. CD44 intron retention in colonic tumour tissues. In: Recent Advances in Gastrolenterological Carcinogenesis. Published by Monduzzi Editore. Editors; Tahara E. and Oohara K.S. 977-982 (1996)
  11. Gorham H, Sugino T, Bolodeoku J, Yoshida K Goodison S, Tarin D
    Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation.
    Journal of Clinical Pathology: Mol. Pathol. 49:147-50 (1996)
  12. Yoshida K., Sugino T., Bolodeoku J, Warren BF, Goodison S, Woodman A, Toge T, Tahara E, Tarin D. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
    Journal of Clinical Pathology 49, 300-305 (1996)
  13. Woodman AW, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, Matsumura Y, Tarin D. Analysis of anomalous CD44 gene expression in human breast, bladder and colon cancer and correlation of observed mRNA and protein isoforms.
    American Journal of Pathology 149, No. 5, 1519-1530 (1996)
  14. Bolodeoku J, Yoshida K, Sugino T, Goodison S, Tarin D.
    Accumulation of immature intron-containing CD44 gene transcripts in breast cancer tissues.
    Molecular Diagnosis Vol 1, No. 3. 175-181 (1996)
  15. Sugino T, Gorham H, Yoshida K, Bolodeoku J, Nargund V, Cranston D, Goodison S, Tarin D. Progressive loss of CD44 gene expression in invasive bladder cancer.
    American Journal of Pathology 149:873-882, (1996)
  16. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, Fellows G, Goodison S, Tahara E, Tarin D.
    Telomerase activity in bladder carcinomas and its implications for non-invasive diagnosis by detection of exfoliated cancer cells in urine
    Cancer 79: 362-369 (1997)
  17. Yoshida K, Sugino T, Goodison S, Warren B, Nolan D,Wadsworth S, Mortensen NJ, Toge T, Tahara E, Tarin D. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.
    British Journal of Cancer 75 (4), 548-553 (1997)
  18. Bolodeoku J, Yoshida K, Sugino T, Churchman M, Goodison S, Tarin D.
    CD44 variant gene transcripts in human breast carcinomas.
    Biochem. Soc. Trans. Vol 25, No. 2 356-357 (1997)
  19. Goodison S, Yoshida K, Sugino T, Woodman AW, Gorham H, Bolodeoku J, Kaufmann M, Tarin D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumours.
    Cancer Research 57, 3140-3144 (1997)
  20. Sugino T, Yoshida K, Bolodeoku J, Tarin D, Goodison S.
    Telomerase activity and its inhibition in benign and malignant breast lesions.
    Journal of Pathology 183, 57-61 (1997)
  21. Goodison S, Ashcroft SJH.
    Trans-acting factor(s) confer glucose-responsive transcriptional regulation in the insulin gene.
    Adv Exp Med Biol 426: 97-101 (1997)
  22. Gorham H, Yoshida K, Sugino T, Marsh G, Charnock M, Tarin D, Goodison S.
    Telomerase activity in human gynaecological tissues.
    Journal of Clinical Pathology Vol 50, 501-504 (1997)
  23. Goodison S., and Tarin D
    The current status of CD44 variant isoforms as cancer diagnostic markers
    Histopathology 32: 1-6 (1998)
  24. Sugino T, Yoshida K, Zhao S, Goodison S, Tarin D.
    Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions.
    Journal of Pathology 186: 17-23 (1998)
  25. Goodison S., and Tarin D.
    Clinical implications of anomalous CD44 gene expression in neoplasia.
    Frontiers in Bioscience 3: 89-109 (1998)
  26. Aogi K, Kitihara K, Buley I, Tahara H, Sugino T, Tarin D, Goodison S.
    Telomerase activity in lesions of the thyroid: Application to diagnosis of clinical samples including fine needle aspirates.
    Clin Cancer Res 4: 1965-1970 (1998)
  27. Urquidi V, Tarin D and Goodison S.
    Telomerase in cancer: clinical applications.
    Annals of Medicine 30: 419-430 (1998)
  28. Goodison S, Yoshida K, Churchman M, Tarin D.
    Multiple intron-retention occurs in tumor cell CD44 mRNA processing.
    Am J Pathol 153(4):1221-8 (1998)
  29. Gorham H, Woodman A, Goodison S, Charnock M, Manek S, Sugino T, Tarin D.
    CD44 expression in human cervical intraepithelial neoplasia and carcinoma.
    Molecular Diagnosis Vol 4. No. 1, 45-57 (1999)
  30. Goodison S, Urquidi V, Tarin D
    The CD44 adhesion molecules
    Molecular Pathology 52:1-7 (1999)
  31. Aogi K, Kitihara K, Urquidi V, Tarin D, Goodison S.
    Comparison of CD44 isoforms and telomerase activity as a diagnostic tumor marker in lesions of the thyroid.
    Clin Cancer Res. 5(10):2790-7 (1999)
  32. Urquidi V, Tarin D, Goodison S.
    Role of telomerase in cell senescence and oncogenesis.
    Annual Rev. Medicine 51: 65-79 (2000)
  33. Woodman A, Goodison S, Drake M, Noble J, Tarin D.
    Non-invasive diagnosis of bladder carcinoma by detection of CD44 isoforms on exfoliated urothelia.
    Clin Cancer Res (6):2381-92. (2000)
  34. Aogi K, Woodman AC, Urquidi V, Mangham DC, Tarin D, Goodison S.
    Telomerase activity in soft tissue and bone sarcoma.
    Clin Cancer Res (6):4776-4781. (2000)
  35. Taniyama K, Goodison S, Ito R, Tarin D, Urquidi V.
    PTEN expression is maintained in sporadic colon cancer.
    J Pathol. (3):341-8 (2001)
  36. Hayashi K., Yokozaki H., Goodison S., Oue A., Suzuki T., Lotan R., Yasui W., Tahara E. Inactivation of retinoic acid receptor-beta by promoter CpG hypermethylation in gastric cancer.
    Differentiation Vol 68:13-21, (2001)
  37. Kawai K, Viars C, Arden K, Tarin D, Urquidi V, Goodison S.
    Comprehensive Karyotyping of the HT-29 colon carcinoma cell line.
    Genes, Chromosomes and Cancer Vol 34: 1-8, (2002)
  38. Urquidi V, Sloan D., Kawai K., Agarwal D., Woodman A., Tarin D., Goodison S.
    Contrasting Expression of Thrombospondin-1 and Osteopontin correlates with absence or presence of metastatic phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis
    Clinical Cancer Research Vol 8:61-74, (2002)
  39. Sugino T, Kusakabe T, Hoshi N, Yamaguchi T, Goodison S, Sekimata M, Homma Y, Suzuki T. An invasion-independent pathway of blood-borne dissemination : A new murine mammary tumor model of metastasis.
    American Journal of Pathology Vol 160 (6); 1973-1980, (2002)
  40. Agarwal D., Goodison S, Nicholson, B., Tarin D, Urquidi V.
    Representational Difference Analysis Reveals a Correlation between MMP8 Expression and Breast Cancer Metastasis.
    Differentiation 71(2):114-25 (2003)
  41. Hayashi K., Goodison S, Urquidi V, Tarin D., Lotan R., Tahara E.
    The effects of all-trans retinoic acid on the growth of matched metastatic and non-metastatic breast cancer cell lines.
    International Journal of Oncology 22(3):623-629 (2003)
  42. Goodison S, Kawai K, Hihara J, Jiang P, Yang M, Urquidi V, Hoffman R, Tarin D.
    Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein.
    Clinical Cancer Research 9:3808-3814 (2003)
  43. Ma H, Urquidi V, Kleeman J, Goodison S.
    Transcriptional Regulation of the hTERT gene during Human Muscle Cell Differentiation
    Molecular Cancer Research 10:739-46 (2003)
  44. J Wang-Rodriguez, V Urquidi, A Rivard, S Goodison.
    Elevated Osteopontin and Thrombospondin Expression Identifies Malignant Human Breast Carcinoma but is not Indicative of Metastatic Status
    Breast Cancer Research Vol 5:136-143 (2003)
  45. Goodison S, Viars C, Grazzini M and Urquidi V.
    The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines.
    BMC Genomics 4:39 (2003)
  46. Sloan DD, Nicholson BE, Urquidi V, Goodison S.
    Detection of differentially expressed genes in an isogenic breast metastasis model using RNA Arbitrarily Primed-PCR coupled with array hybridization (RAP-array)
    American Journal of Pathology 164(1): 315-23 (2004)
  47. RO Stuart, WWachsman, CC Berry, J Wang-Rodriquez, L Wasserman, I Klacansky, D Masys, K Arden, S Goodison, M McClelland, I Kalcheva, and D Mercola.
    In silico extraction of cell-type associated patterns of gene expression in prostate cancer
    Proc. Natl. Acad. Sci. USA 101: 615-620 (2004)
  48. Kreunin P., Urquidi V., Lubman DL., and Goodison S.
    Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique.
    Proteomics 4(9):2754-65 (2004)
  49. Sugino T, Yamaguchi T, Ogura G, Saito A, Goodison S, Suzuki T.
    Morphological evidence for an invasion-independent metastatic pathway exists in multiple human cancers
    BMC Medicine 2;9-15 (2004)
  50. Bertholf RL., and Goodison S.
    Television viewing and attention deficits in children.
    Pediatrics 114(2):511-2. (2004)
  51. Goodison S., Viars C., Urquidi V.
    Molecular cytogenetic study of a human breast tumor metastasis model: Identification of phenotype-specific chromosomal rearrangements.
    Cancer Genetics and Cytogenetics 156; 37-48 (2005)
  52. Goodison, S
    Gene Expression Profiling of Breast Cancer in Ethnic Populations: An Aid to Gene Discovery for the Benefit of All.
    The Breast Journal 11(2):89-91 (2005)
  53. Goodison S, Yuan J, Sloan S, Kim R, Li C, Popescu N, Urquidi V.
    The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.
    Cancer Research 65(14):6042-53 (2005)
  54. Khalbuss W., Ambaya A., Goodison S., Loya A., Masood S.
    Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by Fine Needle Aspiration Biopsy: A case report and review of the literature.
    Diagnostic Cytopathology 34(3):214-7 (2006)
  55. Anai S., Goodison S., Shiverick K., Tanaka M., Hirao Y, Rosser CJ.
    A combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.
    (In Press) (2006)
  56. Ranki T., Kanerva A., Sarkioja M., Kangasniemi L., Raki M., Laakkonen P., Goodison S., Hemminki A.
    A heparin sulphate targeted conditionally replicative adenovirus, Ad5.pK7-?24, for the treatment of advanced breast cancer.
    Gene Therapy (In Press) (2006)
  57. Shuja S, Mohammadi A, Grigorian S, Goodison S.
    Patterns of Cathepsin H Expression in Glioblastoma Multiforme.
    (Submitted)
  58. Khalbuss, W., Goodison S.
    Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology.
    (Submitted)
  59. Sugino T., Yamaguchi T., Ogura G., Kusakabe T., Goodison S., Homma Y., Suzuki T. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway
    (Submitted)
  60. Anai S., Goodison S., Shiverick K., Hirao Y., Brown B., and Rosser CJ.
    Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization in the human PC3 prostate tumor model.
    (Submitted)
  61. Anai S., Tanaka M., Kim W., Takada S., Boehlein S., Goodison S., Shiverick K., Hirao Y., Rosser CJ.
    Increased expression of Cox-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
    (Submitted)
  62. Paweena Kreunin, Chul Yoo, Virginia Urquidi, David M Lubman, Steve Goodison
    Proteomic Profiling Identifies Breast Tumor Metastasis-Associated Candidates in an Isogenic Model.
    (Submitted)
  63. DM. Lubman, NS. Buchanan, FR. Miller, K Cho, R Wu, S Goodison, Y Wang, P Kreunin and T J. Barder. A 2-Dimensional Liquid Mass Mapping Technique for Biomarker Discovery.
    In: Proteomics book (In Press)

Back to Top


Patents
  1. Exon-Link method for CD44-mediated Early Tumor Detection.
    Inventor: S Goodison.
    Publication Date: 1999-01-28
    Patent Number: WO9904036
    IPC Classification: C12Q1/68
  2. Cell type-specific patterns of gene expression in prostate cancer
    US Patent Number: 11/033.056
    S Goodison; Co-Inventor
  3. MMP-8 as a diagnostic marker and/or therapeutic target for metastatic breast cancer.
    US Patent Submitted.

Back to Top


Short Communications - abstracts for presentation at scientific meetings
  1. Goodison S, Ashcroft SJH. The insulin gene 5' regulatory region controls the transcriptional response to glucose and other nutrients. Diabetologia 34 (Supplement 2) A44 p219 (1991)
  2. Yoshida, K., Goodison, S et al . Disturbed CD44 gene activity in colorectal carcinoma-a new abnormality with clinical diagnostic potential. Proceedings of the British Society of Gastroenterology. Abstract 23 (1996)
  3. Bolodeoku J., Yoshida K, Sugino T., Goodison S., Tarin D. Variant exon expression and intron retention in CD44 gene transcripts in human breast carcinomas. Proceedings of the Pathological Society of Great Britain and Ireland. Journal of Pathology Vol 178. Supplement 8A (1996)
  4. Yoshida K., Warren B., Goodison S, Tarin D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastro intestinal tumours. Proceedings of the Pathological Society of Great Britain and Ireland. (1995) Journal of Pathology Vol 178. Supplement 19A (1996)
  5. Woodman AC., Gorham H., Goodison S., Tarin D. Disorganised CD44 gene transcription and translation in colon, breast and bladder cancer: Clinical implications. Proceedings of the American Association of Cancer Research (1996) (Washington, USA) Abstract 606
  6. Goodison S, Yoshida K, Sugino T, Woodman AW, Bolodeoku J, Tarin D. CD44 RNA splicing preferences in colorectal carcinoma. Proceedings of the Pathological Society of Great Britain and Ireland. Journal of Pathology Vol 179. Supplement 39A (1996)
  7. Bolodeoku J, Yoshida K, Sugino T, Churchman M, Woodman A, Goodison S, Tarin D. The expression of CD44 in human breast cancer cell lines Proceedings of the Pathological Society of Great Britain and Ireland. Journal of Pathology Vol 179. Supplement 19A (1996)
  8. Goodison S, Yoshida K, Churchman M, Zhao S, Sugino T, Tarin D. Characterisation of CD44 intron 18 and analysis of its retention in colorectal carcinoma. Proceedings of the Pathological Society of Great Britain and Ireland. Journal of Pathology Vol 179. Supplement 38A (1996)
  9. Goodison S., Yoshida K, Sugino T, Woodman AW, Bolodeoku J, Tarin D. Altered splicing preferences of CD44 in colorectal carcinoma. Proceedings of the 9th International Conference of the International Society of Differentiation. (Pisa, Italy) Abstract 133, Page 120 (1996)
  10. Woodman AC, Sugiyama M, Yoshida K, Gorham H, Goodison S, Matsumura Y, Tarin Clinical implications of disorderly CD44 gene transcription and translation in tumours of the breast, bladder and colon. Proceedings of the 9th International Conference of the International Society of Differentiation. Pisa, Italy) Abstract 277, Page 157 (1996)
  11. Goodison S, Yoshida K, Churchman M, Sugino T, Tarin D. CD44 Intron 18 characterisation and analysis of its retention in colorectal carcinoma mRNA. Proceedings of the 9th International Conference of the International Society of Differentiation. (Pisa, Italy) Abstract 295, Pg 162 (1996)
  12. Yoshida K, Sugino T, Tahara H, Goodison S, Tahara E, Tarin D. Detection of telomerase activity in exfoliated cancer cells in colon luminal washings and its clinical application. Proceedings of the International Conference on Gastroenterological Carcinogenesis. Hiroshima, Japan. Abstract 042, Page 146 (1996)
  13. Bolodeoku J, Yoshida K, Sugino T, Churchman M, Woodman A, Goodison S, Tarin D. The expression of the adhesion molecule CD44 in human breast cancer cell lines in culture. Proceedings of the 9th International Conference of the International Society of Differentiation. (Pisa, Italy) Ab. 51, Pg 99 (1996)
  14. Sugino T., Gorham H., Bolodeoku J., Goodison S., Tarin D. Progressive loss of CD44 gene expression in invasive bladder cancer. Journal of Pathology Vol 179. Supplement 39A (1996)
  15. Goodison S., Yoshida K, Sugino T., Tarin D. CD44 RNA splicing preferences in colorectal carcinoma. Proceedings of the International Conference on Gastroenterological Carcinogenesis. (Hiroshima, Japan) Abstract 017, Page 140 (1996)
  16. Sugino T., Yoshida K., Tarin D., Goodison S. Telomerase activity and its inhibition in benign and malignant breast lesions. Proceedings of the American Association of Cancer Research San Diego, USA Vol 38 Abstract 3401, page 507 San Diego, USA (1997)
  17. Goodison S., Zhao S., Churchman M., Tarin D. Transcriptional regulation of the CD44 gene. Proceedings of the American Association of Cancer Research Vol 38 Abstract 2808, page 419 San Diego, USA (1997)
  18. Goodison S, Yoshida K, Churchman M, Tarin D. Multiple Intron retention in tumour mRNA American Association of Cancer Research, New Orleans 1998 Proceedings of the AACR Vol 39, Abstract #3056, page 449
  19. Aogi K, Tahara H, Tarin D, Goodison S Telomerase activity in thyroid carcinoma American Association of Cancer Research, New Orleans 1998 Proceedings of the AACR Vol 39, Abstract #3689, page 542
  20. Aogi K, Kitahara K, Suzuki S, Toge T, Goodison S, Tarin D. Alteration of telomerase activities in cancer cell lines after anti cancer drug treatment. American Association of Cancer Research, New Orleans 1998 Proceedings of the AACR Vol 39, Abstract #2411, page 353
  21. Woodman A, Goodison S, Sugiyama M, Smith J, Noble J, Matsumura Y and David Tarin. CD44: The measure of bladder cancer Proceedings of the IFCC Conference, Pisa, Italy 1998.
  22. Goodison S, Woodman AC, Noble J, Tarin D. Detection of urothelial neoplasia by CD44 ELISA American Association of Cancer Research, Philadelphia 1999 Proceedings of the AACR Vol 40, Abstract #1587, page 239
  23. Aogi K, Kitahara K, Suzuki S, Toge T, Tarin D, Goodison S. Comparison of CD44 expression and telomerase activity as tumor markers. American Association of Cancer Research, Philadelphia 1999 Proceedings of the AACR Vol 40, Abstract #1771, page 267
  24. Urquidi V, Aogi K, Tarin D, Goodison S. Telomerase activity in soft tissue sarcoma. American Association of Cancer Research, Philadelphia 1999 Proceedings of the AACR Vol 40, Abstract #3971, page 602
  25. D Agarwal, V Urquidi, S Goodison and D Tarin. MMP8 over-expression correlates with metastasis inhibition in a breast carcinoma cell line model. American Association of Cancer Research, San Francisco, 2000 Proceedings of the AACR Vol 41, Abstract #849, page 143
  26. V Urquidi, S Goodison and D Tarin Breast carcinoma clonal cell lines with opposite metastatic phenotype exhibit a significant difference in thrombospondin-1 expression. American Association of Cancer Research, San Francisco 2000 Proceedings of the AACR Vol 41, Abstract #56, page 9
  27. K Taniyama, R Ito, V Urquidi, D Tarin and S Goodison PTEN expression is maintained in sporadic colorectal carcinoma. American Association of Cancer Research, San Francisco 2000 Proceedings of the AACR Vol 41, Abstract #1288, page 202
  28. D Agarwal, V Montel, S Goodison, D Tarin and V Urquidi. Generation of an Angiostatin-like Fragment Correlates with Matrix Metalloproteinase 8 Over-expression and Metastasis Inhibition in a Breast Carcinoma Cell Line. American Association of Cancer Research, New Orleans 2001 Proceedings of the AACR Vol 42, Abstract #3821
  29. K Kawai, C Viars, V Urquidi, D Tarin, K Arden and S Goodison.Comprehensive Karyotyping of the Human HT-29 Colon Carcinoma Cell Line American Association of Cancer Research, New Orleans 2001 Proceedings of the AACR Vol 42, Abstract #354
  30. K Aogi, S Takashima, S Goodison and D Tarin Co-amplification of DNA topoisomerase IIalpha and retinoic acidalpha receptor in topoisomerase-inhibitor treated cancer cell lines.American Association of Cancer Research, New Orleans 2001 Proceedings of the AACR Vol 42, Abstract #1381
  31. H Ma, V Urquidi, J Wong, D Tarin and S Goodison Cell-specific Regulation of hTERT Promoter Activity. American Association of Cancer Research, New Orleans 2001 Proceedings of the AACR Vol 42, Abstract #2643
  32. D Agarwal, M Grazzini, S Goodison, D Tarin and V Urquidi. A Novel Alternatively Spliced Form of Matrix Metalloproteinase 8 Possesses an Altered Hemopexin-like Domain. American Association of Cancer Research, New Orleans 2001 Proceedings of the AACR Vol 42, Abstract #3818
  33. H Ma, V Urquidi, D Tarin and S Goodison. (Invited plenary lecture) Regulation of hTERT mRNA expression in transformed cells. The 9th Taisho International Symposium on Gastroenterology, Shimoda, Japan 2001
  34. The effects of all-trans-retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines Ken Hayashi, Steve Goodison, David Tarin, Reuben Lotan, Eiichi Tahara.
    American Association of Cancer Research, San Francisco 2002. Proceedings of the AACR Vol 43, Abstract #95
  35. hTERT promoter regulation during differentiation of human muscle cell lineages. Steve Goodison, Hongwen Ma, Jeanine Kleeman, Virginia Urquidi. American Association of Cancer Research, San Francisco 2002. Proceedings of the AACR Vol 43, Abstract #1515
  36. Analysis of Gene Expression in Human Breast Cancer Cells Relative to Normal Breast Epithelium By Laser Capture Microscopy and Quantitative PCR Jessica Wang-Rodriguez, Steven Goodison, Virginia Urquidi, David Tarin. American Association of Cancer Research, San Francisco 2002. Proceedings of the AACR Vol 43, Abstract #2260
  37. Tyrosinase related protein 1 (TYRP1) alone is not sufficient to inhibit the metastatic phenotype of human breast cancer cells. Benjamin Nicholson, Dianne Agarwal, Kanji Kawai, Jun Hihara, Steve Goodison, David Tarin, Virginia Urquidi. American Association of Cancer Research, San Francisco 2002. Proceedings of the AACR Vol 43, Abstract #1892
  38. Mapping of the DRIM gene and the quantitative analysis of its expression in a panel of breast tumor cell lines. Steve Goodison, Carrie Viars, Virginia Urquidi, David Tarin. American Association of Cancer Research, San Francisco 2002. Proceedings of the AACR Vol 43, Abstract #1902
  39. Isogenic cell lines cloned from HT29 human colon carcinoma provide new metastasis gene hunting tools. Kanji Kawai, Ping Jiang, Jun Hihara, Steven Goodison, Robert M. Hoffman, David Tarin. American Association of Cancer Research, San Francisco 2002. Proceedings of the AACR Vol 43, Abstract #5259
  40. Spectral karyotyping of a series of breast tumor cell line subclones of known metastatic phenotype. Steve Goodison, Carrie Viars and Virginia Urquidi. CANCER EPIDEM BIOMAR 11 (10): A134 Part 2 OCT 2002
  41. hTERT promoter regulation in reversibly senescent fibroblasts. Virginia Urquidi, Hongwen Ma, and Steve Goodison. CANCER EPIDEM BIOMAR 11 (10): A126 Part 2 OCT 2002
  42. Molecular characterization of monoclonal MDA-435 and MDA-231 breast tumor cell lines of differing tumorigenic and metastatic phenotype. Virginia Urquidi, Jing Yuan, Carrie Viars and Steve Goodison. AACR Mouse models of Cancer Conference, Orlando, FL 2003.
  43. The Induction of hRAD9 and Histone Acetylation is Required for G2/M Checkpoint Signal Transduction in Gastric Cancer Cells. Ken Hayashi, Hiroki Kuniyasu, Naohide Oue, Steve Goodison, Eiichi Tahara, Wataru Yasui. Annual meeting of the American Association of Cancer Research, Toronto 2003. Proceedings of the AACR Vol 44, Abstract #87
  44. Prolonged tumor cell dormancy, success or failure of metastasis and site specific tumor growth potential, analysed using cells labeled with green fluorescent protein (GFP). Steven Goodison, Kanji Kawai, Jun Hihara, Ping Jiang, Meng Yang, Virginia Urquidi, Robert Hoffman, David Tarin, Annual meeting of the American Association of Cancer Research, Toronto 2003. Proceedings of the AACR Vol 44, Abstract #289
  45. Expression of extracellular matrix proteins osteopontin and thrombospondin-1 and of the cell surface serine protease hepsin in ovarian cancer progression. Virginia Urquidi, Reiko Ito, Iveta Kalcheva, Jing Yuan, Steve Goodison. Annual meeting of the American Association of Cancer Research, Toronto 2003. Proceedings of the AACR Vol 44, Abstract #1173
  46. In silico dissection of cell-type associated patterns of gene expression in prostate cancer.
    Robert O. Stuart, William Wachsman, Steven Goodison, Igor Klacansky, Michael McClelland, Jessica Wang-Rodriquez, Linda Wasserman, David Tarin, Dan Mercola, Annual meeting of the American Association of Cancer Research, Toronto 2003. Proceedings of the AACR Vol 44, Abstract #3210
  47. Regulation of the hTERT promoter in immortalized human fibroblasts.
    Virginia Urquidi, Hongwen Ma, Steve Goodison. Annual meeting of the American Association of Cancer Research, Toronto 2003. Proceedings of the AACR Vol 44, Abstract #4192
  48. Comparison of a Support Vector Machine approach and a Nearest Shrunken Centroid approach for the determination of a small set of genes that best classify gene expression data for human prostate carcinoma. Igor Klacansky, William Wachsman, Steven Goodison, Michael McClelland, Jessica Wang-Rodriguez, Dan Mercola, Robert O. Stuart. Annual meeting of the American Association of Cancer Research, Toronto 2003. Proceedings of the AACR Vol 44, Abstract #4287
  49. Urquidi V, Kreunin P, Lubman DM, and Goodison S
    Identification of Metastasis-Associated Proteins using a Mass Mapping Technique
    9th Annual International Breast Symposium 2004, Amelia Island, Florida
  50. Goodison S, Sloan D, Nicholson B, and Urquidi V.
    Detection of candidate breast metastasis genes using RNA Arbitrarily Primed-PCR coupled with array hybridization (RAP-Array). 9th Annual International Breast Symposium 2004, Amelia Island, Florida
  51. David M. Lubman, Paweena Kreunin, Virginia Urquidi, and Steve Goodison
    Identification of Metastasis-Associated Proteins using a Mass Mapping Technique.
    95th Annual meeting of the American Association of Cancer Research, Orlando (2004)
  52. Virginia Urquidi, Jing Yuan, Carrie Viars and Steve Goodison.
    Molecular characterization of monoclonal MDA-435 and MDA-231 breast tumor cell lines of differing tumorigenic and metastatic phenotype. AACR Mouse models of Cancer Conference, Orlando, FL (2003).
  53. Steve Goodison, Abdel Elkahloun, Carrie Viars, Virginia Urquidi
    Molecular profiling of a panel of monoclonal MDA-MB-435 tumor cell lines of differing tumorigenic and metastatic phenotype. 95th Annual meeting of the American Association of Cancer Research, Orlando (2004).
  54. Sugino T, Yamaguchi T, Ogura G, Saito A, Goodison S, Suzuki T.
    Morphological evidence for an invasion-independent metastatic pathway exists in multiple human cancers BioMed Central Open Access Research Bulletin June (2004)
  55. Kreunin P, Urquidi V, Lubman DM, Goodison S. Proteomic profiling identifies breast tumor metastasis-associated candidates. 7th Asian Conference on Analytical Sciences: July 28-31, 2004, Hong Kong.
  56. Kreunin P, Urquidi V, Goodison S, Lubman DM. Differential Proteomics of Metastatic Cancer Cells.
    52nd ASMS Conference: May 23 - 27, 2004, Nashville, Tennessee.
  57. Kreunin P, Urquidi V, Goodison S, Lubman DM. Expression Analysis of Secreted Proteins and the Presence or Absence of Metastatic Behavior in Human MDA-MB-435 Cell Lines by a Mass Mapping Technique. 51st ASMS Conference: June 8-12, 2003, Montreal, Canada.
  58. Goodison S, Viars C, Urquidi V. Molecular cytogenetic profiling of metastatic breast cancer. BreastCancer.Net News. Jan 3rd, 2005
  59. Liu L., Popp M., Liu X., Farmerie WG., Casella G., Goodison S.
    A new Meta-analysis method for microarray studies.
    Third Annual Bioinformatics Workshop. University of Florida (2005).
  60. Satoshi Anai, Steve Goodison, Kenneth Iczkowski, Kathleen Shiverick, Robert Brown, Charles Rosser. Synergistic radio-sensitization by antisense Bcl-2 oligodeoxynucleotide in the PC-3 prostate tumor model overexpressing Bcl-2. Abstract # LB-283. 96th Annual meeting of the American Association of Cancer Research, Anaheim (2005).
  61. Steve Goodison, Derek Sloan, Ryung Kim, Cheng Li, Nicholas Popescu, Virginia Urquidi. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Abstract # 322. 96th Annual meeting of the American Association of Cancer Research, Anaheim (2005).
  62. Satoshi Anai, Steve Goodison, Kenneth Iczkowski, Kathleen Shiverick, Robert Brown, Charles Rosser. University of Florida Prostate Cancer Translational Working Group, Environmental Stressors to Prostatic Cancer Cells In Vitro Cause an Up-Regulation of Cox-2 Expression. UF College of Medicine Research Day, Gainesville. April 2005
  63. Satoshi Anai, Steve Goodison, Kenneth Iczkowski, Kathleen Shiverick, Robert Brown, Charles Rosser. Synergistic radiosensitization by antisense Bcl-2 oligodeoxynucleotide in the PC-3 prostate tumor model overexpressing Bcl-2.
    UF College of Medicine Research Day, Gainesville. April 2005
  64. Satoshi Anai, Steve Goodison, Kenneth Iczkowski, Kathleen Shiverick, Robert Brown, Charles Rosser. The mycoplasmal protein, p37 & its effects on human tumor invasion. UF College of Medicine Research Day, Gainesville. April 2005
  65. Satoshi Anai, Steve Goodison, Kenneth Iczkowski, Kathleen Shiverick, Robert Brown, Charles Rosser. Adenoviral-mediated PTEN transgene expression on human tumor invasion. UF College of Medicine Research Day, Gainesville. April 2005
  66. David M. Lubman, Paweena Kreunin, Virginia Urquidi, Steve Goodison. Department of Pathology, University of Florida, Jacksonville campus. Identification of Metastasis-Associated Proteins using a Mass Mapping Technique.
    UF College of Medicine Research Day, Gainesville. April 2005
  67. Steve Goodison, Li Liu, Mick Popp, Virginia Urquidi. Department of Pathology, University of Florida, Jacksonville Campus. Molecular profiling of a panel of monoclonal MDA-435 tumor cell lines of differing tumorigenic and metastatic phenotype. UF College of Medicine Research Day, Gainesville. April 2005
  68. Kreunin P, Urquidi V, Lubman DM, Goodison S. Breast Tumor Metastasis-Associated Proteins Revealed by 2-D Liquid Separation. 53rd ASMS Conference on Mass Spectrometry, June 5 - 9, 2005. San Antonio, Texas.
  69. Steve Goodison. Cell-type associated patterns of gene expression in prostate cancer. Association of Clinical Scientists' 125th meeting in Troy, Michigan. 2005
  70. Kreunin P, Yoo C, Urquidi V, Lubman DM, Goodison S. Human Tumor Metastasis: Identification of Posttranslational Modifications Using On-line Intact Protein Molecular Mass Characterization and Tandem Mass Spectrometry. 9th Asian Conference on Analytical Sciences: July, 2006, Singapore.
  71. Yipeng Wang, Cecilia Urbina, Anne Sawyers, Steve Goodison, Dan Mercola, Michael McClelland. Karyotype abnormalities and pathway analysis in both prostate tumors and adjacent stroma, Abstract #858 97th Annual meeting of the American Association of Cancer Research, Washington (April, 2006).
  72. Satoshi Anai, Kogenta Nakamura, Steve Goodison, Katherine Shiverick, Bob Brown, Charles J. Rosser. Irradiation increases uptake of antisense oligodeoxynucleotides in human prostate cancer cells. Abstract #2163. 97th Annual meeting of the American Association of Cancer Research, Washington (April, 2006).
  73. Steve Goodison, Mick Popp, Xueli Liu, W G. Farmerie, George Casella, Li Liu. A new meta-analysis method applied to prostate cancer profiles. Abstract #5306. 97th Annual meeting of the American Association of Cancer Research, Washington (April, 2006).
  74. Satoshi Anai, Kogenta Nakamura, Steve Goodison, Kathleen Shiverick, Kenneth Iczkowski, Motoyoshi Tanaka, Charles Joel Rosser. A combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts. Abstract #5314. 97th Annual meeting of the American Association of Cancer Research, Washington (April, 2006).
  75. Kreunin, P, Zhao, J, Lubman, D. M., Urquidi, V., Goodison, S. Characterizing the human urine glycome using lectin affinity chromatography and nanLC-MS/ MS analysis. ProteomLUX 2006 - International conference on proteomics in Luxembourg (Oct 11-14, 2006).

Back to Top